Literature DB >> 7576755

Volume and heterogeneity dependence of the dose-response relationship for head and neck tumours.

A K Agren Cronqvist1, P Källman, I Turesson, A Brahme.   

Abstract

Based on the Poisson statistics of cell kill a model for the response of heterogeneous tumours to non-uniform dose delivery have been developed. The five parameters required to characterize the response are the 50% response dose, D50, the normalized dose-response gradient, gamma, the tumour heterogeneity factor, h, the relative volume, v and the extra daily dose required to counteract the tumour cell proliferation, delta. The model has been fitted to data from a number of clinical investigations to allow the derivation of clinically relevant radiation response parameters for head and neck tumours. The D50 value for T2 larynx cancers is 59.9 Gy in 41 days with a relative standard deviation of 2.1 Gy and the gamma value is 2.9 with a relative standard deviation of 0.3. The value of delta, which is most consistent with the clinical data for laryngeal tumours, is 0.35 Gy/day and this value should be used if the treatment time is changed from the 41 days normalization. The heterogeneity factor, h, is close to zero for laryngeal tumours which indicates that their response is basically governed by Poisson statistics. Nasopharyngeal tumours, on the other hand, exhibit h values around 0.2 which indicates that these tumours are more heterogeneous in their internal organization and so are their responses to radiation.

Entities:  

Mesh:

Year:  1995        PMID: 7576755     DOI: 10.3109/02841869509127196

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  8 in total

1.  Radiobiological analysis of stereotactic body radiation therapy for an evidence-based planning target volume of the lung using multiphase CT images obtained with a pneumatic abdominal compression apparatus: a case study.

Authors:  Arun Chairmadurai; Harish Chandra Goel; Sandeep Kumar Jain; Pawan Kumar
Journal:  Radiol Phys Technol       Date:  2017-11-11

Review 2.  A systems biology approach to radiation therapy optimization.

Authors:  Anders Brahme; Bengt K Lind
Journal:  Radiat Environ Biophys       Date:  2010-02-27       Impact factor: 1.925

3.  Comparisons of treatment optimization directly incorporating random patient setup uncertainty with a margin-based approach.

Authors:  Joseph A Moore; John J Gordon; Mitchell S Anscher; Jeffrey V Siebers
Journal:  Med Phys       Date:  2009-09       Impact factor: 4.071

4.  The use of biologically related model (Eclipse) for the intensity-modulated radiation therapy planning of nasopharyngeal carcinomas.

Authors:  Monica W K Kan; Lucullus H T Leung; Peter K N Yu
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

5.  An integrated strategy of biological and physical constraints in biological optimization for cervical carcinoma.

Authors:  Ziwei Feng; Cheng Tao; Jian Zhu; Jinhu Chen; Gang Yu; Shaohua Qin; Yong Yin; Dengwang Li
Journal:  Radiat Oncol       Date:  2017-04-04       Impact factor: 3.481

6.  Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer.

Authors:  Dalia Ahmad Khalil; Danny Jazmati; Dirk Geismar; Jörg Wulff; Christian Bäumer; Paul Heinz Kramer; Theresa Steinmeier; Stefanie Schulze Schleitthoff; Sandija Plaude; Martin Bischoff; Stephan Tschirdewahn; Boris Hadaschik; Beate Timmermann
Journal:  Radiat Oncol       Date:  2022-04-01       Impact factor: 3.481

7.  Comparison of dose response models for predicting normal tissue complications from cancer radiotherapy: application in rat spinal cord.

Authors:  Magdalena Adamus-Górka; Panayiotis Mavroidis; Bengt K Lind; Anders Brahme
Journal:  Cancers (Basel)       Date:  2011-05-18       Impact factor: 6.639

8.  Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.

Authors:  X Liang; J Penagaricano; D Zheng; S Morrill; X Zhang; P Corry; R J Griffin; E Y Han; M Hardee; V Ratanatharathom
Journal:  Radiat Oncol       Date:  2016-01-22       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.